Skip to content
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

NR metabolites

Biomarker

1 paper studies it

  • Human trial1

Latest

Movement Disorders·Sep 13

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia

Non-randomized trial in 24 peopleNicotinamide riboside
Paper

Related

  • IgG1
  • Immune response1
  • International Cooperative Ataxia Rating Scale1
  • NAD+ metabolism1
  • NAD+ precursors1
  • Purine metabolism1
  • Scale for the Assessment and Rating of Ataxia1
  • Ataxia telangiectasia1
  • Dysarthria1
  • Immunodeficiency1
  • Immunoglobulins1
  • Nicotinamide riboside1
  • Purine nucleosides1
FooterAI assistantsComparePrivacyTermsContactRSSFollow on X
© 2026 AgingResearch.News
Sidebar

    Join AgingResearch.News

    Free: every story, saved papers, follows in a daily email and 3 questions a day to Ask. 14 days of Plus to start, no card.

    Continue with email

    By continuing, you agree to our Terms and Privacy Policy.

    News

    See allSee all news
    Jonathan, the 194-year-old tortoise, shows stable epigenetic regulation of metabolism and DNA repairResearchGEN +7FAHR-Face AI model captures biological aging and disease-related death risk from photographsResearchThe Lancet Digital Health +2Mouse liver zonation erodes by 18 months alongside rising cellular senescenceResearchFight Aging!

    Trials

    See allSee all trials
    Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and WomenResults posted Oct 13, 2026, Marquette UniversityBenefits of Strength Training in Informal Caregivers of Patients With Alzheimer's DiseaseCompleted Oct 16, 2026, University of SalamancaFisetin for Improving Vascular Function in Older Adults: A Phase II Clinical TrialPhase 2Registered Oct 13, 2026, University of Colorado, Boulder

    Trending

    See allSee all trending stories
    Postoperative complicationsDisease15 papers in two weeks, none in the two months beforeSleep durationIntervention18 papers in two weeks, usually 2Moderate-to-vigorous physical activityIntervention12 papers in two weeks, none in the two months beforePerimenopauseDisease12 papers in two weeks, none in the two months beforeVenous thromboembolismDisease12 papers in two weeks, none in the two months beforeMetabolic disordersDisease11 papers in two weeks, none in the two months before

    Topics

    See allSee all topics
    Mechanisms308Interventions630Biomarkers463Populations730AI & data128Industry & policy19SupplementsPeptidesProtocols
    Footer
    • AI assistants
    • Compare
    • Privacy
    • Terms
    • Contact
    • RSS
    • Follow on X
    • © 2026 AgingResearch.News